Published in Cancer Weekly, September 13th, 2005
The Habib4x Resection device is also labeled with the CE Mark for distribution in Europe and is currently marketed by the company's international distribution network. Given the timing of the approval from the FDA and the requirements of a product launch in the U.S., the company expects to begin shipping the product in mid-September 2005. In Europe, the company has seen positive interest in...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.